TickerFacts.

Becton Dickinson & Co (BDX): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2008-09-30, 2010-09-30, 2020-09-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$11.91B
Year ended 2025-09-30
+4.7%
3-year compound annual growth
+5.1%
5-year compound annual growth
2007-09-30: $3.03B2008-09-30: $3.36B2009-09-30: $3.31B2010-09-30: $3.43B2011-09-30: $3.62B2012-09-30: $3.75B2013-09-30: $3.88B2014-09-30: $4.14B2015-09-30: $5.59B2016-09-30: $6.49B2017-09-30: $6.13B2018-09-30: $8.71B2019-09-30: $9.00B2020-09-30: $9.28B2021-09-30: $10.50B2022-09-30: $10.39B2023-09-30: $11.20B2024-09-30: $11.05B2025-09-30: $11.91B$11.91B
2007-09-30 Cost of Revenue (USD) 2025-09-30
Period endedCost of RevenueChange YoYSource filing
2025-09-30$11.91B+7.8%2025-11-25, From 2024-10-01
2024-09-30$11.05B-1.3%2025-11-25, From 2023-10-01
2023-09-30$11.20B+7.8%2025-11-25, From 2022-10-01
2022-09-30$10.39B-1.0%2024-11-27, From 2021-10-01
2021-09-30$10.50B+13.2%2023-11-21, From 2020-10-01
2020-09-30$9.28Bn/c2022-11-22, From 2019-10-01
2019-09-30$9.00B+3.3%2021-11-24, From 2018-10-01
2018-09-30$8.71B+42.2%2020-11-25, From 2017-10-01
2017-09-30$6.13B-5.6%2019-11-27, From 2016-10-01
2016-09-30$6.49B+16.2%2018-11-21, From 2015-10-01
2015-09-30$5.59B+34.8%2017-11-22, From 2014-10-01
2014-09-30$4.14B+6.7%2016-11-23, From 2013-10-01
2013-09-30$3.88B+3.4%2015-11-25, From 2012-10-01
2012-09-30$3.75B+3.6%2014-11-26, From 2011-10-01
2011-09-30$3.62B+5.7%2013-11-27, From 2010-10-01
2010-09-30$3.43Bn/c2012-11-21, From 2009-10-01
2009-09-30$3.31B-1.4%2011-11-23, From 2008-10-01
2008-09-30$3.36Bn/c2010-11-24, From 2007-10-01
2007-09-30$3.03Bn/a2010-01-21, From 2006-10-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Becton Dickinson & Co (BDX)2025-09-30$11.91B+7.8%
Boston Scientific Corp (BSX)2025-12-31$6.22B+18.3%
3M Co (MMM)2025-12-31$14.99B+3.8%
Stryker Corp (SYK)2025-12-31$9.05B+11.0%
Medline Inc. (MDLN)2025-12-31$20.91B+12.9%
Baxter International Inc (BAX)2025-12-31$7.87B+18.2%
ResMed Inc (RMD)2026-06-30$2.20B+5.3%
Dexcom Inc (DXCM)2025-12-31$1.86B+16.6%
MiniMed Group, Inc. (MMED)2026-04-24$1.42B+19.8%

Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗